NPI: 1659780120 · LOS ANGELES, CA 90011 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 08/08/2014
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| Parent Organization | DAVITA INC |
| NPI Enumeration Date | 08/08/2014 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,327 | $2.02M |
| 2019 | 8,421 | $1.16M |
| 2020 | 13,343 | $1.93M |
| 2021 | 18,607 | $2.11M |
| 2022 | 12,427 | $2.22M |
| 2023 | 13,367 | $2.44M |
| 2024 | 10,579 | $2.22M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,467 | 4,544 | $8.20M |
| 0821 | 5,494 | 1,331 | $4.74M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,747 | 1,609 | $657K |
| Z6004 | 185 | 155 | $229K | |
| J1756 | Injection, iron sucrose, 1 mg | 5,234 | 1,951 | $139K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,968 | 851 | $103K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 843 | 494 | $21K |
| A4657 | Syringe, with or without needle, each | 4,303 | 1,329 | $13K |
| 90674 | 175 | 175 | $3K | |
| 83970 | 763 | 742 | $1K | |
| 90662 | 91 | 89 | $1K | |
| 0250 | 1,613 | 123 | $1K | |
| 82108 | 72 | 69 | $831.89 | |
| 82728 | 249 | 236 | $687.82 | |
| 83550 | 209 | 199 | $428.02 | |
| 83540 | 279 | 266 | $328.35 | |
| 85041 | 649 | 619 | $157.11 | |
| 85048 | 644 | 613 | $137.86 | |
| G0008 | Administration of influenza virus vaccine | 33 | 31 | $97.07 |
| 0302 | 39 | 32 | $0.00 | |
| 85045 | 14 | 12 | $0.00 |